Schroder Global Healthcare Fund A Accumulation GBPRegister to Unlock Ratings |
Performance History | 29/02/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 22.0 | 12.6 | -2.3 | 0.7 | 9.3 | |
+/-Cat | 4.5 | 3.2 | 2.4 | 3.9 | 5.8 | |
+/-B’mrk | - | -5.6 | -8.1 | 3.3 | 3.8 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 27/03/2024 | GBP 3.05 | |
Day Change | 0.56% | |
Morningstar Category™ | Sector Equity Healthcare | |
IA (formerly IMA) Sector | Global | |
ISIN | GB0003880183 | |
Fund Size (Mil) 27/03/2024 | GBP 508.97 | |
Share Class Size (Mil) 27/03/2024 | GBP 70.19 | |
Max Initial Charge | - | |
Ongoing Charge 06/02/2024 | 1.67% |
Investment Objective: Schroder Global Healthcare Fund A Accumulation GBP |
The Fund aims to provide capital growth by investing in equity and equity related securities of healthcare and medical related companies worldwide. The Fund is actively managed and invests at least 80% of its assets in equity and equity related securities of companies worldwide, which are engaged in healthcare provision, medical services and related products. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
John Bowler 31/03/2004 | ||
Inception Date 22/05/2000 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI/Health Care NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Schroder Global Healthcare Fund A Accumulation GBP | 30/11/2023 |
|
|
Top 5 Holdings | Sector | % |
Eli Lilly and Co | Healthcare | 8.46 |
Merck & Co Inc | Healthcare | 6.04 |
Novo Nordisk A/S Class B | Healthcare | 5.95 |
UnitedHealth Group Inc | Healthcare | 4.86 |
Thermo Fisher Scientific Inc | Healthcare | 4.84 |
Increase Decrease New since last portfolio | ||
Schroder Global Healthcare Fund A Accumulation GBP |